Pharmacological Activity and Mechanism of Tanshinone IIA in Related Diseases
- PMID: 33192051
- PMCID: PMC7653026
- DOI: 10.2147/DDDT.S266911
Pharmacological Activity and Mechanism of Tanshinone IIA in Related Diseases
Abstract
Salvia miltiorrhiza: (Danshen) is a significant (traditional Chinese medication) natural remedy, enhancing blood circulation and clear blood stasis. In this view, it is widely used against several heart diseases, eg, cardiomyopathy, arrhythmia, and congenital heart defects. Tanshinone IIA (tan-IIA) is the main fat-soluble component of Salvia miltiorrhiza. Modern pharmacological study shows that tan-IIA has anti-inflammatory and anti-oxidant activities. Tan-IIA induces remarkable cardioprotective effects via enhancing angiogenesis which may serve as an effective treatment against cardiovascular diseases (CVD). There is also evidence that tan-IIA has extensive immunomodulatory effects and plays a significant role in the development and function of immune cells. Tan-IIA reduces the production of inflammatory mediators and restores abnormal signaling pathways via regulating the function and activation of immune cells. It can also regulate signal transduction pathways, ie, TLR/NF-κB pathway and MAPKs/NF-κB pathway, thereby tan-IIA has an anti-inflammatory, anticoagulant, antithrombotic and neuroprotective role. It plays a protective role in the pathogenesis of cardiovascular disorders (ie, atherosclerosis, hypertension) and Alzheimer's disease. It has also been revealed that tan-IIA has an anti-tumor role by killing various tumor cells, inducing differentiation and apoptosis, and has potential activity against carcinoma progression. In the review of this fact, the tan-IIA role in different diseases and its mechanism have been summarized while its clinical applications are also explored to provide a new perspective of Salvia miltiorrhiza. An extensive study on the mechanism of action of tan-IIA is of great significance for the effective use of Chinese herbal medicine and the promotion of its status and influence on the world.
Keywords: Alzheimer’ disease; anti-inflammation; anti-oxidative; atherosclerosis; cancer; tanshinone-IIA.
© 2020 Guo et al.
Conflict of interest statement
All authors of this study have no conflict of interest with other people or organizations in promoting the clinical use of tanshinone IIA. The authors report no conflicts of interest for this work.
Figures
Similar articles
-
A comprehensive review of tanshinone IIA and its derivatives in fibrosis treatment.Biomed Pharmacother. 2021 May;137:111404. doi: 10.1016/j.biopha.2021.111404. Epub 2021 Mar 2. Biomed Pharmacother. 2021. PMID: 33761617 Review.
-
Tanshinone IIA attenuates neuroinflammation via inhibiting RAGE/NF-κB signaling pathway in vivo and in vitro.J Neuroinflammation. 2020 Oct 14;17(1):302. doi: 10.1186/s12974-020-01981-4. J Neuroinflammation. 2020. PMID: 33054814 Free PMC article.
-
Signaling pathways behind the biological effects of tanshinone IIA for the prevention of cancer and cardiovascular diseases.Naunyn Schmiedebergs Arch Pharmacol. 2025 Jul;398(7):7877-7902. doi: 10.1007/s00210-025-03857-x. Epub 2025 Feb 12. Naunyn Schmiedebergs Arch Pharmacol. 2025. PMID: 39937254 Review.
-
A network pharmacology approach to investigate the anti-inflammatory mechanism of effective ingredients from Salvia miltiorrhiza.Int Immunopharmacol. 2020 Apr;81:106040. doi: 10.1016/j.intimp.2019.106040. Epub 2019 Dec 6. Int Immunopharmacol. 2020. PMID: 31818704
-
Tanshinone IIA, a component of Salvia miltiorrhiza Bunge, attenuated sepsis-induced liver injury via the SIRT1/Sestrin2/HO-1 signaling pathway.J Ethnopharmacol. 2025 Jan 31;340:119169. doi: 10.1016/j.jep.2024.119169. Epub 2024 Nov 29. J Ethnopharmacol. 2025. PMID: 39617088
Cited by
-
Peptide-Based HDL as an Effective Delivery System for Lipophilic Drugs to Restrain Atherosclerosis Development.Int J Nanomedicine. 2022 Sep 6;17:3877-3892. doi: 10.2147/IJN.S374736. eCollection 2022. Int J Nanomedicine. 2022. PMID: 36097444 Free PMC article.
-
Chinese herbal injection for cardio-cerebrovascular disease: Overview and challenges.Front Pharmacol. 2023 Feb 24;14:1038906. doi: 10.3389/fphar.2023.1038906. eCollection 2023. Front Pharmacol. 2023. PMID: 36909150 Free PMC article. Review.
-
Network pharmacology and experimental study of phenolic acids in salvia miltiorrhiza bung in preventing ischemic stroke.Front Pharmacol. 2023 Jan 27;14:1108518. doi: 10.3389/fphar.2023.1108518. eCollection 2023. Front Pharmacol. 2023. PMID: 36778026 Free PMC article.
-
Salvia Miltiorrhiza Injection Inhibited the Proliferation of AML Cells by Inducing Apoptosis through the p38MAPK Pathway.Cell Biochem Biophys. 2025 Mar;83(1):1263-1275. doi: 10.1007/s12013-024-01560-x. Epub 2024 Sep 29. Cell Biochem Biophys. 2025. PMID: 39342535
-
Targeting NF-κB in diabetic nephropathy: exploring the therapeutic potential of phytoconstituents.Arch Pharm Res. 2025 Aug;48(7-8):577-637. doi: 10.1007/s12272-025-01555-z. Epub 2025 Jul 25. Arch Pharm Res. 2025. PMID: 40707761 Review.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical